SUMMARY Experiments were carried out to assess the susceptibility of normal and inflammatory bowel disease rectal mucus to desulphation and desialation by faecal extracts and by bacterial sialidase. The effects were assessed histochemically using a combined high iron diamine (HID) and alcian blue (AB) stain for sulphomucins and sialomucins. Rectal mucus in biopsies from controls (irritable bowel syndrome) and patients with ulcerative colitis or Crohn's disease was resistant to desialation by Clostridium perfringens sialidase, but susceptible to desialation and desulphation by bacteria-free extracts of normal faeces. Periodic acid-Schiff (PAS) staining of adjacent sections similarly treated showed retention of neutral mucus. One faecal extract selectively desulphated all 42 biopsies, causing the goblet cells to change from HID positive to AB positive, suggesting that most, or all HID positive cells also contain sialomucins. This alters the interpretation of previous histochemical studies. Faecal extracts from patients with active ulcerative colitis (n=6) had desialating and desulphating effects similar to faecal extracts from normal subjects (n=6). Ulcerative colitis (n=21), Crohn's disease (n=18), and control (irritable bowel syndrome) (n=17) rectal biopsies all showed similar susceptibility to desulphation by a pooled normal faecal extract, but rectal biopsies from patients with Crohn's disease proved more resistant to desialation than control or ulcerative colitis biopsies (p<002). These studies imply that colonic mucus undergoes continual desulphation and desialation in vivo as a result of faecal enzyme activity that is probably mainly of bacterial origin. Altered susceptibility of colonic mucus to this may be important in the pathogenesis of colonic disease.
any functional abnormality in ulcerative colitis mucus.
There is relatively little neutral mucus normally present in the colon, most of the mucus being sulphated or sialated.6 Sulphation and sialation may both be potentially important by increasing the resistance of mucus to bacterial degradation. Sulphate groups on subterminal sugars in the mucus glycoprotein increase their charge7 and probably alter the tertiary structure of the mucin as well as rendering the mucin sugars less susceptible to cleavage.8 Sialic acid if present is thought always to be present as a terminal sugar on the mucus glycoprotein side chain.9 As most bacterial glycosidases are probably exoglycosidases -that is, able only to cleave off terminal sugars, the sialic acid would have to be removed by sialidase (neuraminidase) first but histochemical studies have shown that 1312 colonic mucus sialic acid is usually markedly resistant to sialidase, 10 probably as a result of side groups substituted on the sialic acid causing steric hindrance to sialidase." 12 Abnormalities of sulphation or sialation, possibly including abnormalities in the sialic acids themselves, could therefore lead to altered susceptibility to bacterial degradation and hence be of considerable pathogenic importance in colonic disease.
Histochemical techniques are available which distinguish sulphomucins from sialomucins.6 13 In the present study these techniques have been used to determine the susceptibility of normal and diseased rectal mucosae to desulphation and desialation by faecal enzymes.
Methods

PATIENTS
Rectal biopsies were obtained in all from 17 irritable bowel syndrome subjects (controls, aged 20-53 years, all histologically normal) and from 27 patients with ulcerative colitis (aged 18-63 years) and 24 with Crohn's disease (aged 17-65 years) all in clinical remission and diagnosed according to conventional histological and radiological criteria. All the ulcerative colitis patients had had previous active colitis extending at least to the splenic flexure. The ulcerative colitis and Crohn's disease biopsies were all histologically uninflamed or only mildly inflamed without evidence of mucus depletion. Twenty two of the Crohn's disease patients had radiological evidence of ileocolonic disease and the remaining two had ileal disease only. The biopsies were fixed in 10% formal saline and paraffin embedded.
Faecal samples were obtained from eight healthy controls (university students), six patients with active ulcerative colitis and six patients with active Crohn's disease, none of whom had received drug therapy during the previous month. ialidase 0-04 IU/ml with a preliminary experiment two faecal extracts desigcholate 1 mg/ml. (ii) The nated 'S' and 'U' had particularly marked effects on irmal rectal biopsies was, HID/AB staining. Incubation in faecal extract 'S' -d by prior incubation in (from a patient with active ulcerative colitis) was of the 18 faecal extracts found reproducibly to desulphate all rectal biopsies sialating effect; the six tested from controls and patients with ulcerative racts causing less desiala-colitis or Crohn's disease (42 biopsies in all in two mucin grading -1-2±1-6 separate experiments). After incubation in this cal extracts (mean change faecal extract the goblet cells that were sulphomucin 2-4±1-6 sd) or the six containing (HID positive) in buffer-incubated conctracts (mean change in trol sections were found to have been converted to 1-0 sd) (Fig. 1) . Consider-sialomucin staining (AB positive) (Fig. 4) . Incubamucus also resulted from tion in faecal extract 'U' (from a patient with active extracts: normal faecal Crohn's disease) resulted in total loss of all HID/AB n sulphomucin grading staining in all 42 biopsies tested (including controls, tis faecal extracts mean ulcerative colitis and Crohn's disease) although PAS grading -1-1 ± 1-5 sd, staining of adjacent sections similarly treated xtracts mean change in showed preservation of neutral mucins. The de-±1 5 sd (Fig. 2) . Periodic sialating and desulphating effects of faecal extracts jacent sections that had 'S' and 'U' were completely inhibited by addition of ie faecal extracts showed Thimerasyl 100 mglml before incubation of the cins in goblet cells and no rectal biopsies while addition of sodium azide 200 amage (Figs. 3-6 ). (iii) In mg/ml had no effect. The normal, ulcerative colitis and Crohn's disease rectal biopsies showed similar susceptibilities to desialation and desulphation by a faecal extract prepared by pooling six extracts from patients with active ulcerative colitis (Fig. 7) . (Fig. 8) These studies show that normal rectal mucus is susceptible to desialation and desulphation by bacteria free extracts of normal faeces. Inhibition of this effect by Thimerasyl suggests that it is enzyme mediated and the preservation of neutral (PAS positive HID/AB negative) rectal mucus suggests that selective desulphation and desialation have been demonstrated rather than non-specific damage by bacterial proteases or glycosidases present in the faecal extracts. The preservation of neutral mucus suggests that the presence of sialic acid and sulphate ester groups on the rectal mucus confers relative resistance to attack by the mucus degrading glycosidases present in faeces.4 It seems most likely that the faecal sialidase and sulphatase activity is of bacterial origin but it is interesting that Clostridium perfringens sialidase has no effect on rectal sialomucins. Cholera sialidase has also been shown to have very little or no effect on colonic mucus unless the mucosa is previously treated with potassium hydroxide.'0 12 14 It is well recognised, however, that sialidases produced by different organisms may have different substrate specificities.15
It is disappointing that ulcerative colitis rectal mucosa was found to be no more susceptible than normal rectal mucosa to either desialation or desulphation. It is still possible that it might prove more susceptible to a bacterial sulphatase or sialidase present in faeces at the onset of an attack of colitis but absent from the faecal extracts tested in this study. The relative resistance of Crohn's disease rectal mucus to desialation is interesting. It is known that in colonic Crohn's disease there is relative preservation of goblet cell mucus even in the presence of inflammation.2 It is possible that this may be because of increased resistance of Crohn's disease rectal mucus to bacterial degradation. This would at first sight seem to be an advantage and therefore unlikely to be relevant to the pathogenesis of Crohn's disease but increased resistance of the mucus to degration might be associated with some other mucus abnormality, possibly rheological, that is disadvantageous.
In this study extracts prepared from a faecal sample from one patient with active ulcerative colitis were found reproducibly to cause selective desulphation with little desialation of all biopsies tested. It then became clear that all the goblet cells which contained black (HID) staining sulphomucin after incubation in buffer also contained sialomucins as the same crypts could be identified in the adjacent sections treated with this faecal extract and then contained only strongly alcian blue positive (sialomucin containing) cells. This effect was seen in all 42 biopsies incubated in this extract. This suggests that goblet cells that seem with the HID/AB staining technique to contain only sulphomucin also contain sialomucins whose uptake of alcian blue is presumably masked by the intensity of the HID staining. It is possible that the same mucins are both sialated and sulphated or even that the sialic acid is itself sulphated.16 This finding affects the interpretation of previous histochemical studies of colonic mucus where the HID/AB stain has been used. In these studies sialomucins have been identified by deduction as those mucins which stain with AB but not HID because AB at pH 2-5 stains all acid mucinsthat is, both sulphomucins and sialomucins, while HID selectively stains sulphomucins. Increased AB staining in HID/AB stained sections has then been taken to imply increased sialomucin content, as for example in a recent report of altered mucin staining in inflammatory bowel disease and colonic dysplasia. 3 The present study shows, however, that sulphomucin containing goblet cells almost invariably contain sialomucin as well so the only firm conclusion that can be drawn from studies showing reduced HID and incre4sed AB staining is that there is a reduction in sulphomucin. Conclusions about the sialomucin content of mucosa that also contains sulphomucins will therefore have to be based on quantitative biochemical estimation17 18 rather than on histochemical staining patterns.
Although some faecal extracts were found to have a more potent desialating or desulphating effect than others, there was no overall tendency for faecal extracts from patients with active ulcerative colitis or Crohn's disease to have any greater effect on rectal mucus than extracts of faeces from healthy controls. This is in keeping with the results of biochemical estimations of faecal enzyme activity.19 20 In the present study, however, there was a very poor correlation between sulphatase and sialidase activity assayed fluorimetrically and the effects on mucus demonstrable histochemically. This was most marked with faecal sulphatase which has a high pH optimum (pH 8.5)21 when assayed fluorimetrically with little or no activity at pH 6-5 yet histochemically demonstrable desulphation was as marked at pH 6*5 as at pH 7.5. This lack of correlation is likely to be caused by differences in substrate specificity of the faecal sialidases and sulphatases.
It seems likely that colonic mucus is continuously undergoing desialation and desulphation by bacterial enzymes as an initial step in its degradation. While this study has failed to show any differential susceptibility of ulcerative colitis rectal mucus to desialation or desulphation the increased resistance to desialation of Crohn's disease rectal mucus may be of pathogenic importance and might explain why mucus tends to be retained in colonic Crohn's disease even in the presence of inflammation.
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